1. Home
  2. MESO vs IMKTA Comparison

MESO vs IMKTA Comparison

Compare MESO & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesoblast Limited

MESO

Mesoblast Limited

N/A

Current Price

$13.68

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

N/A

Current Price

$84.96

Market Cap

1.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
MESO
IMKTA
Founded
2004
1963
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
2005
1994

Fundamental Metrics

Financial Performance
Metric
MESO
IMKTA
Price
$13.68
$84.96
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $37.00
N/A
AVG Volume (30 Days)
★ 255.3K
78.2K
Earning Date
08-26-2026
11-25-2026
Dividend Yield
N/A
★ 0.78%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
★ $5,334,032,609.00
Revenue This Year
$51.63
N/A
Revenue Next Year
$63.39
N/A
P/E Ratio
★ N/A
$15.91
Revenue Growth
★ N/A
N/A
52 Week Low
$11.89
$67.92
52 Week High
$21.50
$95.62

Technical Indicators

Market Signals
Indicator
MESO
IMKTA
Relative Strength Index (RSI) 46.52 49.30
Support Level $11.89 $82.12
Resistance Level $16.03 $89.28
Average True Range (ATR) 0.50 1.98
MACD 0.07 -0.11
Stochastic Oscillator 40.72 42.54

Price Performance

Historical Comparison
MESO
IMKTA

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: